AgingResearch.News
Frontiers in Immunology

A dual-action humanized DKK-1 antibody that activates the Wnt/β-catenin signaling pathway and inhibits the RANKL signaling pathway for osteoporosis therapy

By Sheng Hou, Tianyu Gao, Yimei Wu, Show 5 more authorsWeizhu Qian
Experiments in cellsInterventions
Paper

The paper

Sheng Hou, Tianyu Gao, Yimei Wu, Show 5 more authorsWeizhu Qian

Liaocheng University

Frontiers in Immunology, 27 Aug 2026

doi.org/10.3389/fimmu.2026.1906434PubMed 42723851

Related